Vets: Need for New AHS Vaccines ‘Urgent’

African horse sickness has the potential to spread due to climate change and increased international horse movement.
Share
Favorite
Close

No account yet? Register

ADVERTISEMENT

As African horse sickness (AHS) threatens to spread outside Africa due to climate change and increased international horse movement, the need for an effective vaccine is becoming urgent, experts from around the world agree.

The disease has up to a 90% mortality rate in unvaccinated horses, which often die within days of exposure. Currently the only vaccines licensed for AHS control are attenuated live virus vaccines, which can “revert to virulence” (meaning they can cause active viruses in the horse), said José-Manuel Sanchez-Vizcaino, DVM, PhD, professor at Complutense University, in Madrid, Spain.

The virus exists in nine serotypes (distinguishable strains), and current vaccines are “polyvalent,” meaning they result in antibodies against most or all the serotypes, he said. However, vaccination with an attenuated live virus can cause just enough viremia (activation of the virus in the horse) to become infectious. For instance, if a midge—the natural vector of transmission of AHS—bites a recently vaccinated horse, it can transport that vaccine-introduced virus to other unvaccinated horses. Those horses will then become subclinically (not showing signs) infected, and midges can spread their disease to more horses, maintaining the virus circulation rather than eliminating it.

While the live attenuated vaccines work well in the endemic countries of sub-Saharan Africa, where the virus is prevalent in midges, these vaccines can become problematic in countries where new outbreaks occur

Create a free account with TheHorse.com to view this content.

TheHorse.com is home to thousands of free articles about horse health care. In order to access some of our exclusive free content, you must be signed into TheHorse.com.

Start your free account today!

Already have an account?
and continue reading.

Share

Written by:

Passionate about horses and science from the time she was riding her first Shetland Pony in Texas, Christa Lesté-Lasserre writes about scientific research that contributes to a better understanding of all equids. After undergrad studies in science, journalism, and literature, she received a master’s degree in creative writing. Now based in France, she aims to present the most fascinating aspect of equine science: the story it creates. Follow Lesté-Lasserre on Twitter @christalestelas.

Related Articles

Stay on top of the most recent Horse Health news with

FREE weekly newsletters from TheHorse.com

Sponsored Content

Weekly Poll

sponsored by:

What do you think: Can pituitary pars intermedia dysfunction (PPID) be managed by medication alone?
126 votes · 126 answers

Readers’ Most Popular

Sign In

Don’t have an account? Register for a FREE account here.

Need to update your account?

You need to be logged in to fill out this form

Create a free account with TheHorse.com!